Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2270329
Max Phase: Preclinical
Molecular Formula: C14H6Cl4N2O
Molecular Weight: 360.03
Molecule Type: Small molecule
Associated Items:
ID: ALA2270329
Max Phase: Preclinical
Molecular Formula: C14H6Cl4N2O
Molecular Weight: 360.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Clc1ccc(-c2nnc(-c3ccc(Cl)cc3Cl)o2)c(Cl)c1
Standard InChI: InChI=1S/C14H6Cl4N2O/c15-7-1-3-9(11(17)5-7)13-19-20-14(21-13)10-4-2-8(16)6-12(10)18/h1-6H
Standard InChI Key: DDMNDFNQRZDZBU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 360.03 | Molecular Weight (Monoisotopic): 357.9234 | AlogP: 6.02 | #Rotatable Bonds: 2 |
Polar Surface Area: 38.92 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.42 | CX LogD: 5.42 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.56 | Np Likeness Score: -1.08 |
1. Shi W, Qian X, Zhang R, Song G.. (2001) Synthesis and quantitative structure-activity relationships of new 2,5-disubstituted-1,3,4-oxadiazoles., 49 (1): [PMID:11170568] [10.1021/jf0007941] |
Source(1):